Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

EUPATI · European Patients' Academy on Therapeutic Innovation

FP7Status: SIGNED1 February 201231 January 2017EU funding €5,250,000

The proposed project ""European Patients' Academy on Therapeutic Innovation"" (EUPATI) contributes to IMI’s goal of raising patients’ awareness and participation in pharmaceutical R&D. This patient-led academy will provide scientifically reliable, objective, comprehensive information to patients on pharmaceutical R&D. It will increase the capacity of well-informed patients to be effective advocates and advisors, e.g. in pharmaceutical development, with regulatory authorities and in ethics committees. The Consortium, led by the European Patients' Forum, comprises a unique combination of pan-European patient organisations, academic and not-for profit organisations and 16 EFPIA member companies. It features excellence across disease areas in state-of-the art, high quality, objective education to patients about therapeutic innovation. Supported by an innovative e-platform, EUPATI's network of patients, experts, companies and communicators develops recognised blended learning courses for patients to become 'Patient Experts' in treatment development. It provides educational materials for patient organisations as well as a Wiki-type platform available to all patients in 6 areas of interest. It drives the newest thinking in content and delivery, and harnesses previously ad-hoc activities in a coherent, strategic, quality-oriented and sustainable way. It informs the lay and hard to reach patient community, raising public awareness of the development of new treatments. EUPATI makes a substantial and measurable difference to patients, laying the base for meaningful involvement and empowerment of patients in pharmaceutical innovation, safety of medicines and access to treatments. EUPATI creates synergies across its public and private partners to galvanize the most effective, transparent and credible partnership possible, nurturing the best that industry and patient organisations can offer in this field, whilst respecting core principles of quality and independence of information.""

Consortium · 33 organisations

coordinator

VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV

DE

participant

PFIZER LIMITED

UK

participant

International Society for Pharmacoeconomics and Outcomes Research Inc

US

participant

THE UNIVERSITY OF MANCHESTER

UK · €609,438

participant

GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED

UK

participant

EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE

BE · €893,637

participant

UCB BIOPHARMA

BE

participant

EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

BE · €56,245

participant

EURORDIS - RARE DISEASES EUROPE

FR · €489,621

participant

NOVARTIS PHARMA AG

CH

participant

MERCK SHARP & DOHME CORP

US

participant

ASTRAZENECA AB

SE

participant

Hibernia College

IE · €384,918

participant

KOBENHAVNS UNIVERSITET

DK · €162,028

participant

AMGEN

BE

participant

DIA Europe GmbH

CH · €738,610

participant

MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

DE

participant

FORUM EUROPEEN DES PATIENTS - EUROPEAN PATIENTS' FORUM

BE · €1,232,402

participant

Bayer Pharma AG

DE

participant

BOEHRINGER INGELHEIM INTERNATIONALGMBH

DE

participant

European Genetic Alliance Network

BE · €301,155

participant

CHIESI FARMACEUTICI SPA

IT

participant

IRISH PLATFORM FOR PATIENTS' ORGANISATIONS SCIENCE AND INDUSTRY LIMITED BY GUARANTEE

IE · €93,276

participant

ESTEVE PHARMACEUTICALS, SA

ES

participant

NOVO NORDISK A/S

DK

participant

SARD

FR

participant

ELI LILLY AND COMPANY LTD

UK

participant

The Employers' Union of Innovative Pharmaceutical Companies INFARMA (Związek Pracodawców Innowacyjnych Firm Farmaceutycznych)

PL

participant

ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA

ES

participant

EUROPEAN AIDS TREATMENT GROUP EV

DE · €288,670

participant

BRISTOL-MYERS SQUIBB COMPANY CORP

US

participant

JANSSEN PHARMACEUTICA NV

BE

participant

F. HOFFMANN-LA ROCHE AG

CH

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.